Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Peest

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|September 1, 1996
Cytokine therapy in multiple myelomaD Peest, J Bladé, J L Harousseau, et al.
Immunitat Und Infektion|April 1, 1984
[Terminal B-cell maturation and immunoglobulin synthesis in vitro in primary and secondary immune deficiencies]U von Bismarck, D Peest, R Dräger, et al.
Transplantation|September 1, 1988
High incidence of monoclonal immunoglobulins in patients after liver or heart transplantationD Peest, B Schaper, B Nashan, et al.
Scandinavian Journal of Haematology|July 1, 1982
T cells in monoclonal gammopathiesH Mellstedt, G Holm, D Pettersson, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Peripheral blood lymphocyte subpopulations in multiple myelomaI Schedel, P Beck, D Peest, et al.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1982
[High-dose immunoglobulin therapy of chronic idiopathic thrombocytopenic purpura in adults]I Schedel, G Plaumann, H Bodenstein, et al.
Annals of Hematology|March 1, 1992
Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cellsR Leo, M Boeker, D Peest, et al.
Clinical and Experimental Immunology|July 1, 1986
Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogensD Peest, S Gasch, C Thiele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancerA Franzke, D Peest, M Probst-Kepper, et al.
Blood|April 1, 1996
Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's LymphomaA Osterborg, M A Boogaerts, R Cimino, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|September 1, 1996
Cytokine therapy in multiple myelomaD Peest, J Bladé, J L Harousseau, et al.
Immunitat Und Infektion|April 1, 1984
[Terminal B-cell maturation and immunoglobulin synthesis in vitro in primary and secondary immune deficiencies]U von Bismarck, D Peest, R Dräger, et al.
Transplantation|September 1, 1988
High incidence of monoclonal immunoglobulins in patients after liver or heart transplantationD Peest, B Schaper, B Nashan, et al.
Scandinavian Journal of Haematology|July 1, 1982
T cells in monoclonal gammopathiesH Mellstedt, G Holm, D Pettersson, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Peripheral blood lymphocyte subpopulations in multiple myelomaI Schedel, P Beck, D Peest, et al.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1982
[High-dose immunoglobulin therapy of chronic idiopathic thrombocytopenic purpura in adults]I Schedel, G Plaumann, H Bodenstein, et al.
Annals of Hematology|March 1, 1992
Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cellsR Leo, M Boeker, D Peest, et al.
Clinical and Experimental Immunology|July 1, 1986
Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogensD Peest, S Gasch, C Thiele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancerA Franzke, D Peest, M Probst-Kepper, et al.
Blood|April 1, 1996
Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's LymphomaA Osterborg, M A Boogaerts, R Cimino, et al.
Pageof 5